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Abstract
Background: Porous tantalum is currently used in orthopaedic surgery for a variety of indications including soft tissue
re-attachment. However, the clinical results have been variable and a previous laboratory study has suggested that
tantalum may actually inhibit chick tendon fibroblasts. The influence of tantalum on human cell-types involved in soft
tissue re-attachment has not been defined.
Methods: Human fibroblasts, human osteoblasts and human mesenchymal stem cells were plated on glass cover slips,
half of which were coated with tantalum. Cell numbers were assessed at 1, 2, 7 and 14 days using Cyquant® assay. Cell
adhesion and morphology were assessed using light microscopy at 7, 14 and 28 days. To reduce the effect of an
expected rate of error, n = 4 was utilised for each cell type and the experiment was repeated twice.
Results: Statistically similar numbers of human osteoblasts and human mesenchymal stem cells were present at 14 days
on tantalum-coated and uncoated glass cover slips, revealing no inhibitory effect on cell proliferation. More than double
the number of human fibroblasts was seen on tantalum-coated cover slips at that time point (compared to controls),
which was statistically significant (p < 0.0001). Morphological assessment revealed normal cell spreading and adhesion on
both substrates at all time points.
Conclusions: In vitro study demonstrates that Tantalum causes a significant increase in the proliferation of human
fibroblasts with no quantifiable negative effects seen on fibroblast behaviour after 28 days culture. Furthermore, tantalum
does not exert any inhibitory effects on the proliferation or behaviour of human osteoblasts or human mesenchymal
stem cells. Tantalum could be an appropriate biomaterial for use in situations where soft tissue requires direct
reattachment to implants and may stimulate soft tissue healing.
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Introduction
Porous tantalum has favourable chemical and mechanical
properties for use as an orthopaedic biomaterial. Its trabe-
culated structure is fabricated by depositing vaporised
tantalum onto a polymerised carbon foam skeleton. (Zar-
diackas et al., 2001) The porous structure has a Young’s
modulus of elasticity that is close to cortical bone. (Levine
et al., 2006) Tantalum exhibits excellent osseointegration
and as a result has an established track record in arthro-
plasty surgery, where its main indication is to address
bone loss, with vascularised bone growing through the in-
terconnected pores in as little as 8 weeks. (Black, 1994)
The potential for porous tantalum to act as a site for the
direct reattachment of soft tissues such as tendons and lig-
aments is also of interest, but less well studied.
With an ageing global population and a higher expect-
ation of function, the demand on revision and salvage
arthroplasty implants is increasing. Loss of bone stock can
include native soft tissue attachment sites (e.g. abductor
mechanism to greater trochanter), affecting implant sta-
bility, joint function and survivorship of the implant. In
these circumstances, (when the native attachment is no
longer present) soft-tissues may require direct reattach-
ment to a weight bearing prosthesis and porous tantalum
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is currently being used in this role. However, the clinical
outcomes of soft-tissue re-attachment to tantalum are less
well studied and perhaps more variable than its ability to
osseointegrate.
Canine supraspinatus reattachment studies have shown
promising results with restoration of function, stability
and locomotion, (Reach et al., 2007; Itälä et al., 2007;
Bobyn et al., 1982; Higuera et al., 2005; Inoue et al., 1995)
but despite this, Reach et al. found that the quality of the
interface between soft-tissues and tantalum implants was
‘histologically poor’ and associated with low mechanical
strength. (Reach et al., 2007) Clinical human studies are
limited in number but have reported restoration of collat-
eral ligament stability around the knee, and abductor
function of the hip, after direct reattachment to tantalum
implants in small numbers of patients. (Chalkin & Minter,
2005; Kwong & Lin, 2010; Holt et al., 2009) In contrast,
tantalum patellar augments used in the management of
the symptomatic post-patellectomy knee, have met with
almost universal failure, unless some residual bone stock
was present. (Jordan et al., 2014; Ries et al., 2006; Tigani
et al., 2009; Kwong & Desai, 2008)
In order to better understand the relationship between
soft-tissue and this material, laboratory studies have
investigated the cellular effects of tantalum, demonstrating
increases in murine osteoblast proliferation, (Ninomiya
et al., 2015; Sagomonyants et al., 2011) canine chondro-
cyte activity (Gordon et al., 2005) and the phagocytic cap-
acity of leukocytes. (Schildhauer et al., 2009) It is the
behaviours of fibroblasts and mesenchymal stem cells in
contact with tantalum, however, that are presumed to be
more important to the success of soft tissue reattachment.
Animal fibroblast studies found that phagocytosis of par-
ticulate tantalum debris inhibited fibroblast proliferation
and, in high enough concentrations, was cytotoxic, (Plenk,
1980; Mostardi et al., 1997) but the effect was not material
specific. Another study found the presence of a porous
tantalum block inhibited chick tendon fibroblast activity,
reducing the cells’ capacity to adhere and produce colla-
gen. (Jordan et al., 2014)
Despite the currently available literature, evidence of
the behaviour of human cells in contact with tantalum is
limited. The aim of this study was to examine the effects
of tantalum on the proliferation and behaviour of human
cell types involved in tissue healing and reattachment of
soft tissues, namely human fibroblasts (HFs), human
mesenchymal stem cells (HMSCs) and human osteo-
blasts (HOBs).
Materials and methods
Circular, glass cover-slips (ø = 13mm, SLS Ltd) were
used to provide a flat substrate with minimal nanotex-
ture. All slides were cleaned (oxygen plasma at 50w for
2 min) and half were coated with vaporised, ‘com-
mercially-pure’ tantalum at a thickness of 50 nm (125
mA Emitch K575x Turbo Splutter Coater, LOT-
QuantumDesign Ltd). All cover slips were sterilised in
70% ethanol inside a laminar flow cabinet. 24-well
plates were prepared with a single coverslip of either
uncoated glass (UG) or tantalum-coated (TC) glass in
the bottom of each well.
Three cell types were studied; HOBs (primary derived
osteoblasts from distal femur), HFs (human fibroblasts)
and HMSCs (C-12972). Cells were plated in each well
on either uncoated glass or tantalum-coated glass cover-
slips with DMEM culture medium (supplemented with
10% Foetal Calf Serum and 1% penicillin/streptomycin),
which was refreshed every 2 days. In every experiment
n = 4 to account for an expected rate of error.
An initial value of 10,000 cells per well was chosen for
all cell types, however in preliminary experiments, fibro-
blast confluence was seen after only 7 days on both sub-
strates. For this reason a lower number of fibroblasts
(1000) was utilised to ensure the substrate remained
sub-confluent, avoiding cell-cell contact inhibition.
Cyquant® assay was performed at 1,2, 7 and 14 days
culture to examine the rate of cell proliferation. Serial
dilutions of known cell numbers were prepared to create
a standard curve for comparison of fluorescent emis-
sions to ascertain cultured cell numbers. This was
Table 1 Mean proliferated cell numbers of Human osteoblasts (HOBs), human mesenchymal stem cells (HMSCs) and human
fibroblasts (HFs) cultured on glass or tantalum-coated glass substrates at 0, 1, 2, 7 and 14 days. Mean variability reported as standard
deviation
0 days 1 day 2 days 7 days 14 days
HOB on glass 10,000 29,938 (±2710) 40,397 (±1805) 70,204 (±1775) 68,723 (±159)
HOB on tantalum 10,000 40,416 (±8126) 45,013 (±1265) 57,086 (±3927) 61,618 (±1105)
HMSC on glass 10,000 22,729 (±684) 21,547 (±2045) 38,042 (±1298) 39,624 (±2704)
HMSC on tantalum 10,000 16,961 (±4809) 24,378 (±1046) 37,068 (±2596) 37,732 (±1231)
HF on glass 1000 1418 (±175) 1096 (±238) 1105 (±208) 3535 (±820)
HF on tantalum 1000 1829 (±596) 1175 (±280) 1339 (±338) 7390 (±1618)
Mean proliferated cell numbers of Human osteoblasts (HOBs), human mesenchymal stem cells (HMSCs) and human fibroblasts (HFs) cultured on glass or tantalum-
coated glass substrates at 0, 1, 2, 7 and 14 days. Mean variability reported as standard deviation
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performed three times for each cell type and an average
taken. The data was submitted to normality testing and
analysed by two-way ANOVA and Tukey’s pair test (p <
0.05). For ease of reading the data in tabulated form
average values were rounded to the nearest hundred.
Each cell type was removed from culture and fixed
(2% paraformaldehyde fixative solution) to enable mor-
phological analysis using light microscopy at 7, 14 and
28 days culture. The entire experiment was repeated
twice to ensure correlation.
Results
Human osteoblasts (HOBs)
After 1 day of culture there was a statistically significant in-
crease in the number of HOBs on TC substrate compared
to UG (p < 0.0001). At 7 days the opposite was observed
with a statistically significant increase in the number of
HOBs on UG (p < 0.0001). By 14 days there was no statis-
tical difference in the cell numbers. (Table 1, Fig. 1).
Light microscopy at 7 days revealed a monolayer of
HOBs on both surfaces, which was denser by 14 days. By
28 days culture, bony spicules were seen protruding from
both substrates that did not wash away with passage or
rinsing. (Fig. 2) There was no discernible difference be-
tween the behaviour of HOBs on the two different sur-
faces, the cells were adherent to the substrates with
cellular projections (lamellipodia and filopodia) and per-
ipheral spreading.
Human Mesenchymal stem cells (HMSCs)
Despite an initial increase in the number of HMSCs on
UG substrate (p < 0.0001) after 1 day, the cells prolifer-
ated at a comparable rate for the rest of the time points.
(Table 1, Fig. 3).
Light microscopy showed the cells to form a consist-
ent, adherent monolayer on both substrates by 7 days
and nodule formation was seen with a range of sizes.
These nodules disappeared during cell passage and rep-
resented dense clumps of colony forming units. By 14
days the cellular nodules were seen denser and larger
(500 μm compared to 200 μm) on the TC slips. (Fig. 4)
By 28 days, cellular senescence was observed on both
substrates.
Human fibroblasts (HFs)
At this lower initial number of cells (1000) there was
no statistical difference in proliferation on the 2 sub-
strates until day 14, when there was a statistically sig-
nificant increase in the number of fibroblasts on TC
substrate (p < 0.0001). The number of fibroblasts on
the TC slips was more than double (7390 ± 1618
(SD)) the number seen on the UG slips (3535 ± 820
(SD)). (Table 1, Fig. 5).
Morphological analysis saw no recognisable difference
in the behaviour of the cells on the two different sur-
faces. Fibroblasts were adherent to both substrates and
Fig. 1 Human Osteoblast (HOBs) proliferation on glass and tantalum-coated glass substrates at 0, 1, 2, 7 and 14 days culture
Fig. 2 Human osteoblasts forming a bony spicule on tantalum-
coated glass (1c)
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were seen to be well-spread with thinning of the cells
around the edges. (Fig. 6) A dense monolayer was
formed by the cells and this became increasingly dense
with time. At 28 days a direct comparison found the
monolayer on the TC substrate to be visibly denser than
on UG.
Discussion
The main findings of this study were that tantalum-
coated glass caused a significant increase in the pro-
liferation of human fibroblasts after 14 days culture,
with no quantifiable negative effects seen on fibroblast
behaviour after 28 days culture. This finding is in
contrast to previous concerns regarding the possibility
of tantalum inhibiting fibroblasts. (Jordan et al., 2014)
This study found no evidence of any inhibitory effect
on the proliferation or cellular morphology of any of
the human cell lineages studied.
Specifically, when observing the morphology of all cell
lineages studied, there was no inhibitory effect seen
when culturing on a tantalum-coated substrate. Tanta-
lum’s osseointegrative success was further supported,
with bony spicules seen forming on the surface of both
substrates. Anchorage dependant cells, such as fibro-
blasts and osteoblasts, require adhesion to an underlying
substrate for survival, (Baxter et al., 2002) and dense,
well-attached monolayers were noted in all cultures,
with the cells spreading, and forming projections (la-
mellipodia and filopodia).
The aforementioned study suggesting that the pres-
ence of tantalum inhibited fibroblasts used chick ten-
don cells and reported inhibition of cellular adhesion,
with rounded, unattached cells floating in the culture
medium and a reduced ability to proliferate and pro-
duce collagen. (Jordan et al., 2014) These effects may
be attributable to the particular cells used, or the
presence of other factors affecting cellular behaviour
such as particulate debris (created by cutting blocks
of porous tantalum), or the nanostructure of the ma-
terial used. (Yim & Leong, 2005; Lim & Donahue,
2007; Barr et al., 2009)
When reviewing the porous material’s ability to inte-
grate with different tissues there are more factors to
consider than purely the metal element used. These
include the structures porosity with large interconnect-
ing pores providing potential for capillary ingrowth to
Fig. 3 Human Mesenchymal Stem Cell (HMSCs) proliferation on glass and tantalum-coated glass substrates at 0, 1, 2, 7 and 14 days culture
Fig. 4 Human Mesenchymal Stem Cells at 7-day culture forming nodules on uncoated glass (a) and tantalum-coated glass (b) substrates
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support vascularised tissue, and also the nanostructure
which has been reported to be stimulatory to certain
cell types. (Plenk, 1980; Yim & Leong, 2005; Lim &
Donahue, 2007; Barr et al., 2009) The macrostructure
of the surface produces a coefficient of friction that can
provide initial interference fixation and therefore stabil-
ity for ingrowth of friable soft tissues.
Human studies, although limited, have met with some
successes. Promising results were seen with functional
restoration after reattachment of the hip abductors and
collateral ligaments around the knee, however, these
prostheses utilised compressive clamps to reattach the
tendon/ligament, which may have allowed functional
restoration without histologically adequate soft tissue
integration into the porous structure for medium term
results. (Chalkin & Minter, 2005; Kwong & Lin, 2010;
Holt et al., 2009) The, almost, universal failure of patella
augments in the absence of host bone may be more
likely attributable to the high mechanical shear stresses
at this tissue-implant interface and a poor biological en-
vironment created by multiple revision surgeries, (Jordan
et al., 2014; Ries et al., 2006; Tigani et al., 2009; Kwong
& Desai, 2008; Gee et al., 2016) than previous sugges-
tions that tantalum may cause fibroblast inhibition
(Jordan et al., 2014).
Despite previous concerns of tantalum causing fibro-
blast inhibition (from a single study using chick tendon
fibroblasts) (Jordan et al., 2014), this new evidence sug-
gests that the reverse is true. The presence of tantalum
itself does not inhibit the human cells required for tissue
healing (HOBs, MSCs or HFs) and actually exerts stimu-
latory effects on HF proliferation by 14 days. With this
new information, we have an improved understanding of
the likely causative factors in the success or failure of
this biomaterial and can discard concerns of cellular in-
hibition by tantalum itself. New manufacturing processes
Fig. 5 Human Fibroblast (HFs) proliferation on glass and tantalum-coated glass substrates at 0, 1, 2, 7 and 14 days culture
Fig. 6 Human fibroblasts forming a dense monolayer on tantalum-coated glass, with cellular adhesion (a). A direct comparison of the density of
the Human Fibroblast monolayer after 28 days on uncoated glass (b) and tantalum-coated glass (c)
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or bio-manipulation could be utilised to enable novel
methods and applications of directly reattaching soft tis-
sues to a tantalum implant with restoration of a more
natural histological attachment and a more predictable
outcome.
Conclusion
In vitro studies demonstrated that tantalum significantly
increased the proliferation of human fibroblasts in direct
contact with no quantifiable negative effects seen on
fibroblast behaviour up to 28 days culture. Furthermore,
tantalum did not exert any inhibitory effects on the pro-
liferation or behaviour of human osteoblasts or human
mesenchymal stem cells. Tantalum could be an appro-
priate biomaterial for use in situations where soft tissue
requires direct reattachment to implants and may stimu-
late soft tissue healing at tissue interfaces.
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